ALERT CENTER: Pfizer to develop Omicron-specific vaccine by March
Rockland-based Pfizer saying an Omicron-specific vaccine will be ready in several weeks.
News 12 Staff
•
Jan 10, 2022, 5:26 PM
•
Updated 835 days ago
Share:
More Stories
Hometown Heroes in the Hudson Valley
7ds ago1:28
Medical experts recommend to still take precautions following CDC's revised COVID isolation guidelines
54ds ago1:52
Judge: 3 men convicted in COVID-19 relief aid fraud
75ds ago1:47
Wondrous Things store in Briarcliff Manor to close after 34 years; everything 25% off
202ds ago0:28
Rockland small businesses get COVID-19 reimbursement grant
202ds ago
Nobel in medicine goes to 2 scientists whose work enabled creation of mRNA vaccines against COVID-19
205ds agoHometown Heroes in the Hudson Valley
7ds ago1:28
Medical experts recommend to still take precautions following CDC's revised COVID isolation guidelines
54ds ago1:52
Judge: 3 men convicted in COVID-19 relief aid fraud
75ds ago1:47
Wondrous Things store in Briarcliff Manor to close after 34 years; everything 25% off
202ds ago0:28
Rockland small businesses get COVID-19 reimbursement grant
202ds agoNobel in medicine goes to 2 scientists whose work enabled creation of mRNA vaccines against COVID-19
205ds agoRockland-based Pfizer saying an Omicron-specific vaccine will be ready in several weeks.
On CNBC today, Pfizer CEO Albert Bourla said that the Omicron-specific vaccine will be ready in March and that the company has already begun manufacturing doses.
Bourla says Pfizer's primary vaccine with a booster shot increases antibody levels capable of fighting off Omicron 25-fold. Whether that's enough will be looked at over the next several weeks.
A Pfizer spokesperson tells News 12 that in the event that their current vaccine and booster are not found to protect against the Omicron variant or other future variants, Pfizer expects “to be able to develop and produce a tailor-made vaccine against that variant in approximately 100 days, subject to regulatory approval."
